Seattle · Pre-Seed–Growth · 32 people tracked
Also known as Bill & Melinda Gates Foundation Trust
Find your way into Bill & Melinda Gates Foundation
5,800 people in our graph share verified history with the Bill & Melinda Gates Foundation team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The Gates Foundation is a philanthropic organization with a mission to create a world where every person has the opportunity to live a healthy, productive life. For over 25 years it has worked with partners worldwide to tackle major global inequities. Its focus areas include global health innovations such as vaccine delivery and disease research, as well as agricultural development and climate-resilient food systems to reduce malnutrition and improve incomes for smallholder farmers. The foundation emphasizes measurable, results-driven outcomes.
Source: firm website, verified Aug 3, 2026.
What founders say
No founder feedback on Bill & Melinda Gates Foundation yet.
Team · 32 people
from the firm's website & curated & public directoriesFounder mafia
The Bill & Melinda Gates Foundation mafia →18 people who came through Bill & Melinda Gates Foundation went on to found or lead other companies.
What they invest in
from 30 of 32 portfolio companiesBiotech ×19Healthtech ×15Medical Devices ×8Digital Health ×7AgTech ×6SaaS ×5Deep Tech ×4Impact & Social Good ×4
HQs:United States×21India×3Germany×1United Kingdom×1Kenya×1Singapore×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 42023 · 22022 · 12021 · 22020 · 22019 · 12018 · 22017 · 12016 · 12015 · 118 dated
ClaremontBio manufactures sample preparation devices and reagents for molecular diagnostics and genomic research, including cell lysis, DNA/RNA extraction, and detection systems.
BiotechDeep TechHardwareMedical DevicesUpland, US
Gary Blackburn(CEO)
Co-investorsIn-Q-Tel
CDD provides software for collaborative research and discovery in biological and chemical sciences, serving scientists and organizations globally.
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareSaaS
Barry Bunin(Founder & CEO)
A searchable database of peer-reviewed evidence on the benefits of immunization, designed for child health advocates, researchers, and policymakers.
Digital HealthHealthtechImpact & Social GoodBaltimore, US
Co-investorsICONIQ
Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions.
AI & Machine LearningDigital HealthHealthtechImpact & Social GoodSaaS
Sameer Sawarkar(Founder and CEO)inRajeev Kumar(Founder and COO)in
Co-investorsHealthQuadVenturEastAxilor Ventures
Pula is an investment and advisory firm that operates an accelerator program in partnership with Nigeria's Sovereign Investment Authority, supporting early-stage ventures in climate resilience, agricultural technology, insurance technology, and regulatory technology across African markets.
AgTechClimate TechInsurTechNairobi, ZA
Thomas Njeru(Co-Founder and CEO)inRose Goslinga(Co-Founder and President)in
Co-investorsAccionInternational Finance CorporationMulago FoundationTLcom CapitalIFC
Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.
Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US
Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in
BoardCharles McDonald(Director)John Maroney(Director)
Co-investorsAvestria VenturesBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesRhia Ventures+6 more
Sanaria develops malaria vaccines designed to prevent infection in at-risk populations worldwide, including pregnant women and children, with long-term goals of mass immunization campaigns and disease elimination.
BiotechHealthtechImpact & Social GoodMedical Devices
Stephen L. Hoffman(CEO)
Stellapps builds the SmartMoo™ full-stack IoT platform that digitizes and optimizes milk production, procurement, and cold-chain management using sensors, big data, and machine learning.
AgTechFoodTechIoTSaaSBangalore, IN
Ranjith Mukundan(CEO)inRamakrishna Adukuri(Founder)inPraveen NaleRavishankar ShiroorinVenkatesh SeshasayeeinYawar Usmaniin
Co-investors500 GlobalBlue Ashva CapitalCelesta CapitalQualcomm VenturesABB Technology VenturesBEENEXT+4 more
Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.
BiotechDeep TechDigital HealthHealthtechBoston, US
Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)
BoardTeymour Boutros-Ghali(Director)inTEYMOUR BOUTROS-GHALI(Director)inMartin Madaus(Director)
Co-investorsBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar PartnersSky9 Capital
This is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth.
Digital HealthE-commerceHealthtechIndia, IN
Co-investorsHBM Healthcare InvestmentsHBM PartnersKae CapitalLeo Capital VenturesPeak XV PartnersSpring Marketing Capital+3 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersLeaps by BayerNovalis LifeSciences+1 more
Aphea.Bio develops bioinsecticides targeting sap-sucking insects that damage crops, in partnership with Bayer to accelerate their development.
AgTechBiotech
Isabel Vercauterenin
Co-investorsAstanor VenturesEuropean Circular Bioeconomy FundInnovation IndustriesPMVV-Bio VenturesVIVES Partners+2 more
BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology.
BiotechMedical DevicesNew MaterialsAshland, US
Tina M Phaneuf(Executive Officer and Director of Manager)inMatthew D. Phaneuf(Executive Officer and Director of Manager)in
BoardThomas L Barrette(Director of Manager)
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.
BiotechDeep TechHealthtechBoston, US
Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)
Co-investorsSherpa Healthcare Partners
BiotechCambridge, US
Bobby Herrara(Executive Officer)Bobby Brooke Herrera(Cofounder)Ann DeWitt(Director)Prashant Chouta(Executive Officer, Director)
Co-investorsBlue Ivy VenturesCastor VenturesKhosla Ventures
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+8 more
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.
BiotechFemTechHealthtech
Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)
Co-investorsAngelini VenturesIndaco Venture PartnersOMX VenturesSofinnova Partners
GBS is a German manufacturer of modular email security and management software, including its iQ.Suite, offering threat protection alongside governance, risk and compliance (GRC) capabilities.
CybersecurityEnterprise SoftwareSaaS
Co-investorsWalnut Venture Associates
Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.
BiotechCambridge, US
Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)
Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaAuriga Partners+1 more
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechMedical DevicesWellness & FitnessSacramento, US
David J. Kyle(Executive Officer, Director)inJ. Bruce German(Co-founder)David Mills(Co-founder)inCarlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)in
Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundLongitude CapitalSpruce Capital Partners+1 more
Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines.
BiotechHealthtechRedmond, US
Subhash Kapre(Manager, Co-CEO)inPradip Ghate(Chief Operating Officer)inDavid Goesling(Chief Financial Officer)inYves Leurquin(Manager, Co-CEO)in
Loowatt develops a patented waterless, chemical-free flush toilet that seals waste in a lining and offers end-to-end sanitation-as-a-service, including servicing and processing of waste into biogas and fertiliser via anaerobic digestion.
Circular EconomyCleantechHardware
Virginia Gardiner(CEO + Founder)in
Co-investorsAngel AcademeOxford Investment Opportunity Network (OION)
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity.
AI & Machine LearningBiotechHealthtechSeattle, US
Ivan Liachko(Executive Officer, Director, Promoter)inShawn Sullivan(Executive Officer, Promoter)in
Co-investorsAlliance of AngelsCongruent VenturesHemi Ventures, Llc
Puna Bio develops microbial biostimulants, biofertilizers, and biofungicides for seed treatment based on extremophile bacteria collected from Argentina's Puna region, aimed at improving crop yields and regenerating degraded soils.
AgTechBiotechClimate TechSan Francisco, US
Maria Eugenia Farias(Executive Officer)inCarolina Belfiore(Executive Officer)inElisa Violeta Bertini(Executive Officer, Director)inFranco Martinez Levis(Executive Officer, Director)inFranco Martínez LevisinMaría Eugenia Faríasin
Co-investorsAIR CapitalAt One VenturesCapria VenturesGLOCAL LatamGRIDXSOSV+4 more
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration PartnersAmplitude Venture Capital
Revital Healthcare is a medical device manufacturer producing disposable medical products, including auto-disable and reuse-preventing syringes, bCPAP systems for newborns, and rapid diagnostic tests, with a portfolio of 48 devices.
Advanced ManufacturingHealthtechMedical Devices
Co-investorsAsia Africa Investment & Consulting (AAIC)
SwipeRx operates a digital network for independent pharmacies and pharmacy professionals across Southeast Asia, offering community tools and a purchasing platform for buying quality medicines.
B2B MarketplacesDigital HealthHealthtechMarketplacesSaaS
Farouk Meralli(Founder)inJon LininYee Fong Ten
Co-investors500 GlobalKickstart VenturesPatamar CapitalSpiral VenturesMDI Ventures
Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering.
AgTechBiotechClimate TechDeep TechHealthtechImpact & Social GoodSan Diego, US
Nikolay Kandul(Co-founder & CEO)inOmar Akbari(Co-founder & CSO)Pooja Y. Patel(Co-founder & CBO)inRavi Solanki(Co-founder)in
Co-investorsNuFund Venture GroupService Provider CapitalAntlerRedbudRedbud VC
Portfolio news
latest coverage across their companies
Aphea · agfundernews.com · Jun 11, 2026
Ensoma · finsmes.com · Sep 23, 2025
Puna Bio · prnewswire.com · Jul 16, 2025
Syntis Bio · finsmes.com · Jul 1, 2025
Revital Healthcare · revitalhcare.com · May 1, 2025
Frequently asked questions
- How many investments has Bill & Melinda Gates Foundation made?
- Bill & Melinda Gates Foundation has 32 tracked investments, 2 of which have exited, including 2 dated in the last 24 months.
- What stage does Bill & Melinda Gates Foundation invest at?
- Bill & Melinda Gates Foundation invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Bill & Melinda Gates Foundation focus on?
- Bill & Melinda Gates Foundation focuses on AgTech, Digital Health, EdTech, Fintech, FoodTech, Healthtech, Impact & Social Good.
- Where is Bill & Melinda Gates Foundation located?
- Bill & Melinda Gates Foundation is headquartered in Seattle, US.
Media · Podcasts & interviews
featuring the team“India one of most important voices of Global South” Bill & Melinda Gates Foundation CEO Mark Suzman
ANI News · Mark Suzman
In Conversation with Mark Suzman, CEO of Bill & Melinda Gates Foundation
DD India · Mark Suzman
Yahoo Finance Presents: Mark Suzman, Bill & Melinda Gates Foundation CEO
Yahoo Finance · Mark Suzman
Mark Suzman, CEO, Bill & Melinda Gates Foundation - OECD DAC@60
archive-OECD Development Co-operation · Mark Suzman
Mark Suzman, CEO at The Bill & Melinda Gates Foundation — A Fireside Conversation at Harvard
HPAIR · Mark Suzman
Mark Suzman, CEO, Bill & Melinda Gates Foundation- Oxford Africa Conference 2021
Oxford Africa Conference · Mark Suzman
Images
Similar investors
Saviu Ventures is an Africa-focused growth capital fund backing early-stage tech and tech-enabled companies, with a particular emphasis on Francophone Africa.
2050 is a mission-driven venture capital firm that invests in companies aligning their economic development with the interests of people, society and the planet. Its fund is structured to remain open for 99 years and is governed by a Perpetual Purpose Trust.
This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).
IDB Lab is the innovation and venture arm of the Inter-American Development Bank Group, supporting entrepreneurial innovation and disruptive technologies to benefit vulnerable populations and activate new industries for sustainable growth in Latin America and the Caribbean.
Innovation UBC is the University of British Columbia's research commercialization and innovation unit, supporting researchers in translating discoveries into ventures, licensed technologies and industry collaborations.
































































1575275080338.jpg?format=auto&w=1920&q=75)




































































.png)








































